Malignant Hepatobiliary Neoplasm — Trials

Malignant Hepatobiliary Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,029 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,160
Recruiting: 666
Ph III recruiting: 61
Growth YoY: +9.3%
Industry share: 22%
Top sponsor: Sun Yat-sen University
Termination share: 32.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (561)

clinicaltrialsPublishedShowing 201–250 of 1,150 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05971199	Phase II Study of Fruquintinib Combined With Sintilimab and TACE for Inoperable Primary Hepatocellular Carcinoma	unknown	Phase 2	27	Zhejiang Cancer HospitalOTHER	1	Aug 2, 2023	clinicaltrials
NCT05967429	Predictors of Sorafenib Response in HCC	unknown	—	80	Sohag UniversityOTHER	0	Aug 1, 2023	clinicaltrials